Soroka University Medical Center
Clinical trials sponsored by Soroka University Medical Center, explained in plain language.
-
New daily pill aims to control hepatitis d virus
Disease control CompletedThis study tested a once-daily combination of two drugs, lonafarnib and ritonavir, in 10 people with chronic hepatitis D. The goal was to see if the treatment is safe and can lower virus levels over 48 weeks, with a 24-week follow-up. Participants had stable liver disease and wer…
Phase: PHASE3 • Sponsor: Soroka University Medical Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Experimental COVID-19 drug shows promise in small pilot trial
Disease control CompletedThis study tested whether adding pegylated interferon lambda to standard care helps hospitalized COVID-19 patients recover faster. Nine adults with mild to moderate symptoms were randomly assigned to receive either the drug plus standard care or standard care alone. The main goal…
Phase: PHASE2 • Sponsor: Soroka University Medical Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Minutes vs. days: new rapid test could speed up thyroid cancer detection
Diagnosis CompletedThis study tested a new rapid test (POC-Tg) that measures thyroglobulin levels in fluid from a lymph node biopsy to quickly detect if thyroid cancer has spread. Currently, patients wait days to weeks for results. The new test aims to give results in minutes, helping doctors make …
Sponsor: Soroka University Medical Center • Aim: Diagnosis
Last updated May 14, 2026 12:02 UTC
-
Can an elliptical trainer help MS patients walk better?
Symptom relief CompletedThis study tested whether aerobic exercise on an elliptical trainer or a treadmill improves walking, balance, and stability in people with multiple sclerosis. Thirty adults with moderate MS completed the exercise programs. The goal was to see which machine offers greater benefits…
Phase: NA • Sponsor: Soroka University Medical Center • Aim: Symptom relief
Last updated May 17, 2026 11:03 UTC